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When cyanide is introduced into the body, it quickly transforms
through a variety of chemical reactions, normally involving sulfur
donors, to form more stable chemical species. Depending on the
nature of the sulfur donor, cyanide may be transformed into free
thiocyanate, the major metabolite of cyanide transformation,
2-amino-2-thiazoline-4-carboxylic acid or protein-bound thiocyanate
(PB-SCN) adducts. Because protein adducts are generally stable in
biological systems, it has been suggested that PB-SCN may have
distinct advantages as a marker of cyanide exposure. In this study,
plasma was analyzed from 25 smokers (chronic low-level cyanide
exposure group) and 25 non-smokers for PB-SCN. The amount of
PB-SCN found in the plasma of smokers, 1.35 mM, was significant-
ly elevated (p < 0.0001) when compared to non-smokers, 0.66 mM.
Differences in sub-groups of smokers and non-smokers were also
evaluated. The results of this study indicate the effectiveness of
analyzing PB-SCN in determining instances of chronic cyanide ex-
posure with possible extension to confirmation of acute cyanide
exposure.
Introduction
Cyanide exposure through dietary sources, such as almonds
and cassava root (1–2), inhalation of smoke from fires, work
in the mining and metallurgy fields (3), and occupations in
plastics manufacturing and chemical production all contribute
to chronic exposure to cyanide. Another significant source of
chronic cyanide exposure is the act of smoking (4–5), in
which smokers are introduced to small doses of cyanide
through cigarette smoke inhalation. Chronic exposure to
cyanide, even at low levels, can promote the development of
serious health conditions, including myelin degeneration and
abnormal thyroid activity (6–7). A study by Philbrick et al. (8)
determined that chronic cyanide exposure could cause signifi-
cant detriment to a person’s overall health, including irrevers-
ible damage of the nervous system. This study contributed to
EPA regulated cyanide exposure limits of 30 mg kg21/day21.
When cyanide enters the body, it quickly transforms into
less toxic metabolites (t1/2 ¼ 0.34–1.0 h in biological fluids)
(9), which makes direct analysis of cyanide unreliable under
most circumstances. Therefore, a more stable marker of
cyanide exposure could more dependably be used to confirm
exposure (10–13). Free thiocyanate is the major metabolite of
cyanide exposure and is produced from the reaction of cyanide
with free sulfur donors (e.g., thiosulfate) in the presence of
rhodanese (14–15). Although thiocyanate has a longer half-life
than cyanide in biological fluids [t1/2 ¼ 96–192 h (9–13)],
low-dose cyanide exposure is difficult to positively confirm
from the analysis of free thiocyanate because large, and highly
variable, endogenous background concentrations in biological
fluids (16) cannot be exclusively attributed to cyanide metabol-
ism (17–19). For example, broccoli, cauliflower and cabbage
contain substantial levels of thiocyanate (20–21) and thiocyan-
ate is associated with antibacterial activity in saliva (22–23).
Another marker of cyanide exposure is produced when
cyanide reacts with cystine to form 2-amino-2-thiazoline-4-
carboxylic acid (ATCA) (24). Although recent studies have
shed some light on its value as a marker of cyanide exposure
(11, 24, 25), little is known about ATCA, including its half-life
in biological systems. Alternatively, a recently suggested marker
of cyanide exposure is produced when cyanide reacts with di-
sulfide bonds in proteins to form protein-bound thiocyanate
(PB-SCN) (26, 27, 28). Although the half-life of PB-SCN is
unknown, if the protein adduct is stable, the half-life should be
similar to that of the parent protein in blood [25 days for
albumin (29–31) and 55 days for hemoglobin (32)]. The
current study showed that chronic cyanide exposure, as
modeled by exposure to cigarette smoke, could be determined
through the analysis of plasma PB-SCN.
Experimental
Materials
Sodium thiocyanate, sodium cyanide, tetrabutylammonium
sulfate (TBAS), concentrated HCl, ethyl acetate, acetone,
sodium carbonate and stable-isotope labeled potassium thio-
cyanate (KS13C15N) were obtained from Sigma-Aldrich
(St. Louis, MO). Pentafluorobenzyl bromide (PFBBr) was
acquired through Thermo Scientific (Hanover Park, IL). All sol-
vents used in this study were at least HPLC grade. All aqueous
solutions were prepared with deionized, distilled water (18.2
MV cm) from a LabConco Water Pro PS system. A stock solu-
tion of approximately 100 mM thiocyanate was used to prepare
all standard solutions.
Human plasma samples
In this study, the concentrations of PB-SCN from a total of 50
human (Homo sapiens) plasma samples were studied. Of these
50 subjects, 25 smoked regularly, and the remaining 25 sub-
jects were classified as non-smokers based on a questionnaire
that evaluated the number of cigarettes smoked daily, the type
of cigarette and subjects’ potential to be exposed to cyanide
via other routes. Non-smokers were included to provide a base-
line level of PB-SCN incurred from sources other than smoking,
such as diet and environment. Blood samples from each of the
subjects were collected, centrifuged to isolate the plasma, and
mixed with an EDTA anti-coagulant to prevent protein
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coagulation. Samples were kept in a freezer at approximately
–858C until analysis.
Five males and 20 females comprised the group of 25
smokers, while seven males and 18 females made up the non-
smokers group. None of the subjects were involved in an occu-
pation in which chronic cyanide exposure was considered
likely or were prescribed any medication that would expose
them to low levels of cyanide (e.g., sodium nitroprusside). No
individuals were pregnant at the time the plasma samples were
collected and none of the non-smokers indicated significant
exposure to second-hand cigarette smoke. Collection and ana-
lysis of human samples was approved prior to this study by the
Human Subjects Advisory Committees at South Dakota State
University, the Avera Medical Institute (Sioux Falls, SD), and the
Human Research Protection Office of the U.S. Army Medical
Research and Materiel Command (Ft. Detrick, MD).
Protein-bound thiocyanate analysis
Protein-bound SCN was analyzed from plasma samples accord-
ing to the method previously described by Youso et al. (27),
with minor modifications. Briefly, plasma proteins were precipi-
tated, washed to remove free thiocyanate and dissolved in a
carbonate buffer (pH 10) to release bound thiocyanate moi-
eties from the protein. The extracted thiocyanate was then
derivatized for analysis using PFBBr. The derivatized thiocyan-
ate was extracted into ethyl acetate and analyzed using
electron ionization gas chromatography–mass spectrometry
(GC–MS parameters described by Youso et al. (27)). PB-SCN
concentrations for each plasma sample tested were well above
the detection limit of the analytical method (approximately
40 nM).
Quantification and data analysis
Quantification of thiocyanate was achieved by stable isotope
dilution with the internal standard KS13C15N. Standard thio-
cyanate solutions with concentrations of 100–1,000 ng/mL
were prepared by diluting the stock thiocyanate solution to
achieve the desired concentration. The internal standard
(100 mg/mL) was added to each standard and sample. Data are
reported in the format mean+ standard deviation with the
standard error of the mean (SEM) in parenthesis.
To statistically evaluate the plasma samples for significant differ-
ences in the PB-SCN concentrations of smokers compared with
non-smokers, a two-tailed t-test was executed. Additional statistic-
al analysis of different sub-groups of smokers and non-smokers
(e.g., groups sorted by the average number of cigarettes smoked
per day) was completed using analysis of variance (ANOVA)
testing with Tukey’s and Bonferroni’s multiple range tests to de-
termine significant differences between each sub-group.
Results
Comparison of smokers and non-smokers
Figure 1 illustrates the individual concentrations of PB-SCN iso-
lated from the plasma of each smoker and non-smoker, along
with the mean concentration of PFB-SCN for each group (solid
line in each group). The mean PB-SCN concentration in the
plasma of smokers was found to be approximately twice that of
non-smokers, 1.35+0.51 mM (SEM ¼ 0.10) and 0.66+0.34 mM
(SEM ¼ 0.07), respectively, with concentration ranges of 2.26–
0.47 mM for smokers and 1.58–0.15 mM for non-smokers.
Although the ranges of PB-SCN concentrations overlap
(Figure 1), the concentrations fall within a relatively narrow
range, especially for non-smokers. The percent relative stand-
ard deviations for PB-SCN were 38 and 51% for smokers and
nonsmokers, respectively. Statistical evaluation of the data
revealed a significant difference (p, 0.0001) at a very high
confidence level between the PB-SCN concentrations of
smokers and non-smokers.
Statistically, PB-SCN compares favorably to other markers of
cyanide exposure. For comparable studies, markers of cyanide
exposure normally have significantly elevated concentrations in
the biological fluids (i.e., urine, blood, and saliva) of smokers
(i.e., p, 0.05 for a t-test). But for most studies, the significance
is not as strong as that found for PB-SCN (16). This is, in part,
due to the relatively low variability of plasma PB-SCN concen-
trations compared to other markers of cyanide exposure (16).
Specifically, the percent relative standard deviations for other
studies range from 7–100% for cyanide (33, 34), 10–140% for
thiocyanate (35, 36), and 30–102% for ATCA (16–17).
Significant concentrations of PB-SCN found in non-smoker
plasma are indicative of endogenous cyanide or cyanide expos-
ure from sources other than cigarette smoke, such as food or
environmental exposure.
Comparison of gender differences
The smoker and non-smoker groups were separated into sub-
groups (e.g., male smokers compared to female smokers) to de-
termine if factors besides smoking status produced statistical
differences in PB-SCN concentrations. Figure 2 shows the indi-
vidual PB-SCN concentrations grouped by gender, with the
number of participants and the mean concentration of PB-SCN
reported in Table I.
Differences in gender did not significantly affect plasma
PB-SCN concentrations in the study population (p. 0.05).
Comparisons of smoker and non-smoker groups, no matter the
gender, resulted in significant differences between each of
Figure 1. The concentration of PB-SCN found in the plasma samples of smokers
compared to non-smokers. The individual data points represent the concentration of
PB-SCN in each sample. The solid line represents mean concentration of each group.
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the groups (p, 0.05). Although the population of males in the
current study was low, the similarity in the concentrations of
PB-SCN found for males and females indicates that gender does
not affect the plasma PB-SCN concentrations. The similarity of
PB-SCN concentrations across genders is a desirable character-
istic of a marker of cyanide exposure.
Daily cigarette consumption
Smoking participants were also grouped according to daily cigar-
ette consumption. The average plasma PB-SCN concentrations
found for these groups are reported in Table II and the individ-
ual concentrations are displayed in Figure 3. Overall, there was a
wide range of cigarettes smoked daily by the smoking partici-
pants (5 to 30) with an average of 16.2 cigarettes consumed per
day. As visually evident in Figure 3 and confirmed by an ANOVA
(with the multiple range tests described), no correlation could
be made between the number of cigarettes smoked per day and
the levels of PB-SCN found. Previous studies have also found no
correlation between daily cigarette consumption and concentra-
tions of cyanide and thiocyanate (37–39), although some studies
have found a correlation (12, 36, 40–42).
Discussion
The major goal of this study was to more firmly establish or to
disprove the correlation between chronic low-level cyanide
exposure (i.e., smoking) and concentrations of plasma PB-SCN
found by Youso et al. (27). A secondary goal was to determine
baseline concentrations and variability of PB-SCN for smokers
and non-smokers, which must be known to use this marker to
determine involuntary cyanide exposure. Statistically, the con-
centrations of PB-SCN are clearly significantly different when
comparing smokers and non-smokers (p , 0.0001). However,
the strong significant difference does not necessarily offer
insight into the type of correlation between the marker and
the toxic agent exposure. To help support the relationship of a
proposed marker with a parent agent, we have previously sug-
gested using the ratio of a high-level exposure group (e.g.,
smokers) to a low-level exposure group (e.g., non-smokers)
within the same study (16, 25), henceforth referred to as a bio-
marker concentration ratio (BCR). Comparing BCR values of
the parent agent and a proposed marker can help quantify the
relationship of the proposed marker to the parent agent inde-
pendent of variability in sampling, storage, or analysis techni-
ques. Similar BCRs for the parent agent and the proposed
marker indicate a strong relationship. BCRs are particularly
important for the evaluation of cyanide markers because of the
extreme effects of sampling, storage and analysis methods on
certain markers of cyanide exposure (16). For this study, the
PB-SCN BCR is 2.0, which compares favorably to intra-study
blood cyanide BCRs of 1.2–3.1 (16). The similar BCR between
cyanide and PB-SCN suggests a strong correlation of PB-SCN
with cyanide exposure. For the other markers of cyanide
exposure, the BCR of free thiocyanate in blood ranges from
1.7–7.1 (16) and the only study of plasma ATCA concentrations
produced a BCR of 1.5 (25). This indicates that processes
besides cyanide exposure may contribute to free thiocyanate
[which is also supported by other studies (18, 19)], but that
PB-SCN and ATCA are correlated well to cyanide exposure.
The concentration of PB-SCN was independent of gender
(i.e., p. 0.05 for sub-groups of males and females) and did not
correlate significantly with reported daily cigarette consump-
tion. The lack of correlation with apparent cyanide dose (i.e.,
number of cigarettes smoked daily) may be due to a number of
Table I
Plasma Protein-Bound Thiocyanate Concentrations for Each Group and Sub-Group of Participants
Group N Sub-group N [SCN]bound (mM)
Male 12 Smokers 5 1.55+ 0.58 (SEM ¼ 0.28)
Non-smokers 7 0.66+ 0.31 (SEM ¼ 0.12)
Female 38 Smokers 20 1.31+ 0.49 (SEM ¼ 0.11)
Non-smokers 18 0.64+ 0.37 (SEM ¼ 0.09)
Table II
Plasma Protein-Bound Thiocyanate Concentrations Found for Each Group of Smokers (Grouped by
Number of Cigarettes per Day)
Number of cigarettes per day N [SCN]bound (mM)
25 5 1.07+ 0.35 (SEM ¼ 0.14)
20–24 4 1.58+ 0.62 (SEM ¼ 0.31)
15–19 8 1.37+ 0.61 (SEM ¼ 0.21)
5–14 8 1.41+ 0.42 (SEM ¼ 0.15)
Figure 2. Individual concentrations of PB-SCN found in the plasma of male smokers
(MS), male non-smokers (MNS), female smokers (FS) and female non-smokers
(FNS). The solid line represents mean concentrations of the group.
Figure 3. Individual concentrations of protein-bound thiocyanate found in the plasma
samples of male and female smoking sub-groups separated based on the number of
cigarettes consumed daily. The solid line represents the mean concentrations of each
sub-group.
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factors. One potential factor in the consistency of plasma
PB-SCN of smokers (Figure 3) is long-term accumulation of
thiocyanate in plasma proteins. Long-term accumulation of
PB-SCN would dilute the relationship between cyanide dose
and PB-SCN considering that there is a finite number of avail-
able sites in the protein for reaction with cyanide (27).
Another key issue is variability in smoking behavior related to
an individual’s ability to consume a desired dose of nicotine
from a cigarette (43, 44). Other factors, including smoking
history, frequency (i.e., the consistency of an individual in
smoking a certain number of cigarettes per day), differences in
cigarette brands smoked, and inaccurate estimation of daily cig-
arette consumption by the participants, may also contribute to
the lack of correlation of PB-SCN concentrations with apparent
daily cigarette consumption. The relationship between PB-SCN
and cyanide dose must be further evaluated.
Future studies will include the analysis of PB-SCN after acute
cyanide exposure, the determination of the half-life of PB-SCN,
and a similar study to the present one, but with an expanded
study population (with greater control over the number of
people admitted within each smoking group desired) to verify
endogenous levels of the proposed marker of cyanide
exposure.
Acknowledgments
The research was supported by the CounterACT Program,
National Institutes Of Health Office of the Director and the
National Institute of Allergy and Infectious Diseases, Inter
Agency Agreement Number Y1-OD-0690-01/A-120-B.P2010-01
and the USAMRICD under the auspices of the US Army
Research Office of Scientific Services Program Contract No.
W911NF-11-D-0001 administered by Battelle (Delivery order
0079, Contract No TCN 11077). We gratefully acknowledge
funding from the National Institutes of Health and the
Department of Defense through the Cyanide Medical
Countermeasures and the Medical Diagnostics research areas.
The opinions or assertions contained herein are the private
views of the authors and are not to be construed as official or
as reflecting the views of the National Institutes of Health,
Department of the Army or the Department of Defense.
References
1. Eminedoki, D.G., Monanu, M.O., Anosike, E.O. (1994) Thiocyanate
levels of mainly dietary origin in serum and urine from a human
population sample in Port Harcourt, Nigeria. Plant Foods for
Human Nutrition, 46, 277–285.
2. Murray, S., Lake, B.G., Lake, S., Edwards, A.J., Springall, C., Bowey,
E.A. et al. (2001) Effect of cruciferous vegetable consumption on
heterocyclic aromatic amine metabolism. Carcinogenesis, 22,
1413–1420.
3. Baud, F.J., Barriot, P., Toffis, V., Riou, B., Vicaut, E., Lecarpentier, Y.
et al. (1991) Elevated blood cyanide concentrations in victims of
smoke inhalation. New England Journal of Medicine, 325,
1761–1766.
4. Scherer, G. (2006) Carboxyhemoglobin and thiocyanate as biomar-
kers of exposure to carbon monoxide and hydrogen cyanide in
tobacco smoke. Experimental and Toxicolologic Pathology, 58,
101–124.
5. Forsyth, J.C., Mueller, P.D., Becker, C.E., Osterloh, J., Benowitz, N.L.,
Rumack, B.H. et al. (1993) Hydroxycobalamin as a cyanide antidote:
Safety, efficacy, and pharmacokinetics in heavily smoking normal
volunteers. Clinical Toxicology, 31, 277–294.
6. Ghawabi, S.H.E., Gaafar, M.A., El-Saharti, A.A., Ahmed, S.H., Malash,
K.K. (1975) Chronic cyanide exposure: A clinical, radioisotope, and
laboratory study. Occupational and Environmental Medicine, 32,
215–219.
7. Manzano, H., Benedito de Sousa, A., Soto-Blanco, B., Guerra, J.L.,
Maiorka, P.C., Gorniac, S.L. (2007) Effects of long term cyanide in-
gestion by pigs. Veterinary Research Communications, 31,
93–104.
8. Philbrick, D.J., Hopkins, J.B., Hill, D.C., Alexander, J.C., Thomson,
R.G. (1979) Effects of prolonged cyanide and thiocyanate feeding
in rats. Toxicology and Environmental Health, 5, 579–592.
9. Baskin, S.I., Kelly, J.B., Maliner, B.I., Rockwood, G.A., Zoltani, C.K.
(2008) Cyanide poisoning. In Tuorinsky, S.D. (ed.), Textbook of
military medicine, medical aspects of chemical and biological
warfare. Borden Institute, Washington, DC, pp. 371–410.
10. Ishii, A., Seno, H., Suzuki, K.W., Suzuki, O. (1998) Determination of
cyanide in whole blood by capillary gas chromatography with cryo-
genic oven trapping. Analytical Chemistry, 70, 4873–4876.
11. Lundquist, P., Rosling, H., Sorbo, B., Tibbling, L. (1997)
Determination of cyanide in whole blood, erythrocytes, and
plasma. Clinical Chemistry, 33, 1228–1230.
12. Tsuge, K., Kataoka, M., Seto, Y. (2000) Cyanide and thiocyanate
levels on blood and saliva of healthy adult volunteers. Journal of
Health Science, 46, 343–350.
13. Baskin, S.I., Petrikovics, I., Kurche, J.S., Nicholson, J.D., Logue, B.A.,
Maliner, B.J. et al. (2004) Insights on cyanide toxicity and methods
of treatment. In Flora, S.J.S., Romano, J.A., Jr., Baskin, S.I., Sekhar, K.
(eds.) Pharmacological perspectives if toxic chemicals and their
antidotes. Narosa Publishing, New Delhi, India, pp. 105–146.
14. Baskin, S.I., Porter, D.W., Rockwood, G.A., Romano, J.A., Patel, H.C.,
Kiser, R.C. et al. (1999) In vitro and in vivo comparison of sulfur
donors as antidotes to acute cyanide intoxication. Journal of
Applied Toxicology, 19, 173–183.
15. Frankenberg, L. (1980) Enzyme therapy in cyanide poisoning:
Effect of rhodanese and sulfur compounds. Archives of Toxicology,
45, 315–323.
16. Logue, B.A., Hinkens, D.M., Baskin, S.I., Rockwood, G.A. (2010) The
analysis of cyanide and its breakdown products in biological
samples. Critical Reviews in Analytical Chemistry, 40, 122–147.
17. Isom, G.E., Baskin, S.I. (1997) Enzymes involved in cyanide metabol-
ism. In Sipes, I.G., McQueen, C.A., Gandolfi, A.J. (eds.)
Comprehensive toxicology. Elsevier Science, New York, NY, pp.
477–488.
18. Wood, J.L., Williams, E.F.J., Kingsland, N. (1947) The conversion of
thiocyanate sulfur to sulfate in the white rat. Journal of Biological
Chemistry, 170, 251–259.
19. Wood, J.L., Williams, E.F.J. (1949) The metabolism of thiocyanate in
the rat and its inhibition by propylthiouracil. Journal of Biological
Chemistry, 177, 59–67.
20. Sanchez, C.A., Blount, B.C., Valentin-Blasini, L., Krieger, R.I. (2007)
Perchlorate, thiocyanate, and nitrate in edible coal crops (Brassica
sp.) produced in the lower Colorado River region. Bulletin of
Environmental Contamination and Toxicology, 79, 655–659.
21. Heaney, R.K., Fenwick, G.R. (1980) The analysis of glucosinolates in
Brassica species using gas chromatography: Direct determination of
the thiocyanate ion precursors, glucobrassicin and neoglucobrassi-
cin. Journal of the Science of Food and Agriculture, 31, 593–599.
22. Thomas, E.L., Milligan, T.W., Joyner, R.E., Jefferson, M.M. (1994)
Antibacterial activity of hydrogen peroxide and the
lactoperoxidase-hydrogen peroxide-thiocyanate system against oral
streptococci. Infection and Immunity, 62, 529–535.
23. Clem, W.H., Klebanoff, S.J. (1966) Inhibitory effect of saliva on glu-
tamic acid accumulation by lactobacillus acidophilus and the role
of the lactoperoxidase-thiocyanate system. Journal of Bacteriology,
91, 1848–1853.
268 Youso et al.
24. Logue, B.A., Kirschten, N.P., Petrikovics, I., Moser, M.A., Rockwood,
G.A., Baskin, S.I. (2005) Determination of the cyanide metabolite 2--
aminothiazoline-4-carboxylic acid in urine and plasma by gas
chromatography-mass spectrometry. Journal of Chromatography
B, 819, 237–244.
25. Logue, B.A., Maserek, W.K., Rockwood, G.A., Keebaugh, M., Baskin,
S.I. (2009) Analysis of the cyanide metabolite, 2-amino-2-thiazoline-
4-carboxylic acid, in plasma and its feasibility as a retrospective
marker of cyanide exposure. Toxicology Mechanisms and
Methods, 19, 202–208.
26. Fasco, M.J., Hauer, C.R., Stack, R.F., O’Hehir, C., Barr, J.R., Eadon,
G.A. (2007) Cyanide adducts with human plasma proteins: Albumin
as a potential exposure surrogate. Chemical Research in
Toxicology, 20, 677–684.
27. Youso, S.L., Rockwood, G.A., Lee, J.P., Logue, B.A. (2010)
Determination of cyanide exposure by gas-chromatography mass-
spectrometry analysis of cyanide-exposed plasma proteins.
Analytica Chimica Acta, 677, 24–28.
28. Fasco, M.J., Stack, R.F., Lu, S., Hauer, C.R., III, Schneider, E., Dailey,
M. et al. (2011) Unique cyanide adduct in human serum albumin:
potential as a surrogate exposure marker. Chemical Research in
Toxicology, 24, 505–514.
29. Sterling, K. (1951) The turnover rate of serum albumin in man as
measured by I131-tagged albumin. Journal of Clinical
Investigation, 30, 1238–1242.
30. Noort, D., Benschop, H.P., Black, R.M. (2002) Biomonitoring of ex-
posure to chemical warfare agents: A review. Toxicology and
Applied Pharmacology, 184, 116–126.
31. Turner, P.C., Dingley, K.H., Coxhead, J., Russell, S., Garner, C.R.
(1998) Detectable levels of serum aflatoxin B1-adducts in the
United Kingdom population: Implications for aflatoxin-B1 exposure
in the United Kingdom. Cancer Epidemiology, Biomarkers &
Prevention, 7, 441–447.
32. Coghlin, J., Gann, P.H., Hammond, S.K., Skipper, P.L., Taghizadeh, K.,
Paul, M. et al. (1991) 4-Aminobipheny1 hemoglobin adducts in
fetuses exposed to the tobacco smoke carcinogen in utero.
Journal of the National Cancer Institute, 83, 274–280.
33. Sano, A., Takezawa, M., Takitani, S. (1989) Spectrofluorometric de-
termination of cyanide in blood and urine with naphthalene-2,3-
dialdehyde and taurine. Analytica Chimica Acta, 225, 351–358.
34. Lundquist, P., Rosling, H., So¨rbo, B. (1985) Determination of
cyanide in whole blood, erythrocytes, and plasma. Clinical
Chemistry, 31, 591–595.
35. Hasuike, Y., Nakanishi, T., Moriguchi, R., Otaki, Y., Nanami, M.,
Hama, Y. et al. (2004) Accumulation of cyanide and thiocyanate in
haemodialysis patients. Nephrology Dialysis Transplantation, 19,
1474–1479.
36. Hassan, S.S.M., Badr, I.H.A., Kamel, A.H., Mohamed, M.S. (2009) A
novel poly(vinyl chloride) matrix membrane sensor for batch and
flow-injection determinations of thiocyanate, cyanide and some
metal ions. Analytical Sciences, 25, 911–917.
37. Demkowska, I., Polkowska, Z., Namiesnik, J. (2008) Application of
ion chromatography for the determination of inorganic ions, espe-
cially thiocyanates in human saliva samples as biomarkers of envir-
onmental tobacco smoke exposure. Journal of Chromatography
B, 875, 419–29.
38. Levine, M.S., Radford, E.P. (1978) Occupational exposures to
cyanide in Baltimore fire fighters. Journal of Occupational
Medicine, 20, 53–56.
39. Pre, J., Vassy, R. (1992) Plasma thiocyanate and cigarette-smoking
status. Medical Science Research, 20, 671–672.
40. Connolly, D., Barron, L., Paull, B. (2002) Determination of urinary
thiocyanate and nitrate using fast ion-interaction chromatography.
Journal of Chromatography B, 767, 175–180.
41. Hassan, S.S.M., Mohmoud, W.H., Elgazwy, A.S.H., Badawy, N.M.
(2006) A novel potentiometric membrane sensor based on aryl pal-
ladium complex for selective determination of thiocyanate in the
saliva and urine of cigarette smokers. Electroanalysis, 18,
2070–2078.
42. Yamanaka, S., Takaku, S., Takaesu, Y., Nishimura, M. (1991) Validity
of salivary thiocyanate as an indicator of cyanide exposure from
smoking. Bulletin of Tokyo Dental College, 32, 157–163.
43. Benowitz, N.L., Hall, S.M., Herning, R.I., Jacob, P., III, Jones, R.T.,
Osman, A.-L. (1983) Smokers of low yield cigarettes do not
consume less nicotine. New England Journal of Medicine, 309,
139–142.
44. Benowitz, N.L., Jacob, P., III, Kozlowski, L., Yu, L. (1986) Influence
of smoking fewer cigarettes on exposure to tar, nicotine, and
carbon monoxide exposure. New England Journal of Medicine,
314, 1310–1313.
The Analysis of Protein-Bound Thiocyanate in Plasma of Smokers and Non-Smokers as a Marker of Cyanide Exposure 269
